DENVER -- The combination injectable cabotegravir-rilpivirine (CAB-RPV; Cabenuva) safely maintained long-term viral suppression among adolescents with HIV who switched from daily oral medications, ...

The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...

Semaglutide (Ozempic®, Wegovy®, Rybelsus®) comes in both injection and oral form. But beyond how you take it, what’s the difference? And which form is more effective for weight loss? Semaglutide ...

Oral Wegovy shifts GLP-1 obesity costs: insurance may match injectables, while cash-pay and pharmacy platforms unlock lower prices and aid programs. From a manufacturing and logistics standpoint, oral ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

When Lindsey Boynton was offered the option to give herself her birth control shot at home, she was surprised the option even existed. The method — self-injected subcutaneous depot medroxyprogesterone ...

Patients who switched to once-daily oral orforglipron from injectable Wegovy or Zepbound successfully maintained their previously achieved weight loss at 52 weeks. Study participants were randomly ...

PAI Pharma has acquired Nivagen Pharmaceuticals in a move it said was aimed at expanding the domestic supply of sterile injectable drugs. Nivagen operates a recently built aseptic manufacturing ...

Removing part or all of the breast during breast cancer treatment is a potential outcome for some people. Reconstructive surgical procedures often involve prosthetic implants or transplanted tissue ...

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says. Nemolizumab (Nemluvio) relieved itchiness within two days for three ...

Eli Lilly has shown patients maintained most of their weight loss after switching from injectable GLP-1s to its oral drug candidate, teeing the drugmaker up to target people taking Novo Nordisk’s ...

Patients who switched to once-daily oral orforglipron from injectable Wegovy or Zepbound successfully maintained their previously achieved weight loss at 52 weeks. The randomized, double-blind, ...